Garry Cooper

560 total citations
27 papers, 449 citations indexed

About

Garry Cooper is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Garry Cooper has authored 27 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Garry Cooper's work include Lymphatic System and Diseases (13 papers), Diagnosis and Treatment of Venous Diseases (9 papers) and Ion channel regulation and function (4 papers). Garry Cooper is often cited by papers focused on Lymphatic System and Diseases (13 papers), Diagnosis and Treatment of Venous Diseases (9 papers) and Ion channel regulation and function (4 papers). Garry Cooper collaborates with scholars based in United Kingdom, United States and South Korea. Garry Cooper's co-authors include D. James Surmeier, Soosung Kang, Richard B. Silverman, Sara F. Dunne, Chi-Hao Luan, James E. Robbins, Herbert E. Kaufman, Chi‐Hao Luan, Wei Xu and Ping Xie and has published in prestigious journals such as Nature Communications, Journal of Neurophysiology and Journal of Medicinal Chemistry.

In The Last Decade

Garry Cooper

27 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Garry Cooper United Kingdom 10 161 130 89 74 67 27 449
Ho K. Lee South Korea 10 320 2.0× 66 0.5× 44 0.5× 31 0.4× 60 0.9× 12 708
Rocío González‐Corrochano Spain 12 176 1.1× 132 1.0× 17 0.2× 80 1.1× 11 0.2× 15 613
Osamu Hirai Japan 15 132 0.8× 228 1.8× 16 0.2× 125 1.7× 225 3.4× 55 712
Kathleen M. McEvoy United States 14 172 1.1× 200 1.5× 25 0.3× 59 0.8× 584 8.7× 20 859
İclal Gürses Türkiye 11 68 0.4× 29 0.2× 13 0.1× 53 0.7× 34 0.5× 28 376
Leonóra Himer Hungary 8 127 0.8× 49 0.4× 47 0.5× 56 0.8× 15 0.2× 8 557
Weijian Zhu China 13 80 0.5× 47 0.4× 53 0.6× 109 1.5× 14 0.2× 29 435
Cara A. Timpani Australia 15 581 3.6× 48 0.4× 90 1.0× 41 0.6× 26 0.4× 34 803
Chiemi Sato Japan 15 174 1.1× 66 0.5× 69 0.8× 97 1.3× 13 0.2× 35 600

Countries citing papers authored by Garry Cooper

Since Specialization
Citations

This map shows the geographic impact of Garry Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry Cooper more than expected).

Fields of papers citing papers by Garry Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry Cooper. The network helps show where Garry Cooper may publish in the future.

Co-authorship network of co-authors of Garry Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Garry Cooper. A scholar is included among the top collaborators of Garry Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry Cooper. Garry Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooper, Garry & Donna Brown. (2024). Integrating compression therapy into heart failure and lymphoedema management. British Journal of Community Nursing. 29(Sup10). S6–S9. 1 indexed citations
2.
Cooper, Garry, Soosung Kang, Tamara Perez‐Rosello, et al.. (2021). Correction to A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium Channels. ACS Chemical Biology. 16(7). 1299–1300. 1 indexed citations
3.
Cooper, Garry. (2018). The impact of chronic oedema on quality of life in the elderly. British Journal of Community Nursing. 23(Sup4). S10–S12. 8 indexed citations
4.
Cooper, Garry. (2017). A wealth of information to apply to lymphoedema management. British Journal of Nursing. 26(4). 200–202. 2 indexed citations
5.
Cooper, Garry. (2016). Genetics and lymphoedema: a future yet to be fully discovered. British Journal of Community Nursing. 22(1). 646–648. 3 indexed citations
6.
Cooper, Garry, et al.. (2016). Prevalence of lymphoedema in the UK: focus on the southwest and West Midlands. British Journal of Community Nursing. 21(Sup4). S6–S14. 34 indexed citations
7.
Cooper, Garry. (2016). Chronic oedema: its prevalence, effects and management. British Journal of Community Nursing. 21(Sup10). S32–S36. 2 indexed citations
8.
Cooper, Garry, Alon Simchovitz, Ronit Sharon, et al.. (2015). Functional segregation of voltage-activated calcium channels in motoneurons of the dorsal motor nucleus of the vagus. Journal of Neurophysiology. 114(3). 1513–1520. 12 indexed citations
9.
Xu, Wei, Seok Jong Hong, Garry Cooper, et al.. (2014). Hydration Status Regulates Sodium Flux and Inflammatory Pathways through Epithelial Sodium Channel (ENaC) in the Skin. Journal of Investigative Dermatology. 135(3). 796–806. 57 indexed citations
10.
Cooper, Garry. (2014). Practical barriers to achieving self-management of lymphoedema. British Journal of Community Nursing. 19(Sup10). S14–S20. 5 indexed citations
11.
Kang, Soosung, Garry Cooper, Sara F. Dunne, et al.. (2013). Antagonism of L-type Ca2+ channels CaV1.3 and CaV1.2 by 1,4-dihydropyrimidines and 4H-pyrans as dihydropyridine mimics. Bioorganic & Medicinal Chemistry. 21(14). 4365–4373. 38 indexed citations
12.
Cooper, Garry. (2013). Lymphoedema prevalence in the West Midlands region. 2 indexed citations
13.
Cooper, Garry. (2013). Compression therapy in chronic oedema and lymphoedema. Nursing and Residential Care. 15(3). 134–139. 5 indexed citations
14.
Kang, Soosung, Garry Cooper, Sara F. Dunne, et al.. (2013). Structure–Activity Relationship of N,N′-Disubstituted Pyrimidinetriones as CaV1.3 Calcium Channel-Selective Antagonists for Parkinson’s Disease. Journal of Medicinal Chemistry. 56(11). 4786–4797. 27 indexed citations
15.
Kang, Soosung, Garry Cooper, Sara F. Dunne, et al.. (2012). CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease. Nature Communications. 3(1). 1146–1146. 136 indexed citations
16.
Cooper, Garry. (2012). Lymphoedema treatment in palliative care: a case study. British Journal of Nursing. 21(15). 897–903. 8 indexed citations
17.
Cooper, Garry. (2011). Early diagnosis of lymphoedema helps to reduce its psychological and social impact.. PubMed. 106(49-50). 15–7. 9 indexed citations
18.
19.
Goodman, Neville W., et al.. (1984). The validity of informed consent in a clinical study. Anaesthesia. 39(9). 911–916. 8 indexed citations
20.
Kaufman, Herbert E., et al.. (1964). Corneal Toxicity of Cytosine Arabinoside. Archives of Ophthalmology. 72(4). 535–540. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026